Cargando…
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983835/ https://www.ncbi.nlm.nih.gov/pubmed/35390296 http://dx.doi.org/10.1016/j.ccell.2022.03.013 |
| _version_ | 1784682044097298432 |
|---|---|
| author | Aleman, Adolfo Van Oekelen, Oliver Upadhyaya, Bhaskar Beach, Katherine Kogan Zajdman, Ariel Alshammary, Hala Serebryakova, Kseniya Agte, Sarita Kappes, Katerina Gleason, Charles R. Srivastava, Komal Almo, Steve Cordon-Cardo, Carlos Krammer, Florian Merad, Miriam Jagannath, Sundar Wajnberg, Ania Simon, Viviana Parekh, Samir |
| author_facet | Aleman, Adolfo Van Oekelen, Oliver Upadhyaya, Bhaskar Beach, Katherine Kogan Zajdman, Ariel Alshammary, Hala Serebryakova, Kseniya Agte, Sarita Kappes, Katerina Gleason, Charles R. Srivastava, Komal Almo, Steve Cordon-Cardo, Carlos Krammer, Florian Merad, Miriam Jagannath, Sundar Wajnberg, Ania Simon, Viviana Parekh, Samir |
| author_sort | Aleman, Adolfo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8983835 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89838352022-04-06 Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients Aleman, Adolfo Van Oekelen, Oliver Upadhyaya, Bhaskar Beach, Katherine Kogan Zajdman, Ariel Alshammary, Hala Serebryakova, Kseniya Agte, Sarita Kappes, Katerina Gleason, Charles R. Srivastava, Komal Almo, Steve Cordon-Cardo, Carlos Krammer, Florian Merad, Miriam Jagannath, Sundar Wajnberg, Ania Simon, Viviana Parekh, Samir Cancer Cell Letter Elsevier Inc. 2022-05-09 2022-04-06 /pmc/articles/PMC8983835/ /pubmed/35390296 http://dx.doi.org/10.1016/j.ccell.2022.03.013 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Aleman, Adolfo Van Oekelen, Oliver Upadhyaya, Bhaskar Beach, Katherine Kogan Zajdman, Ariel Alshammary, Hala Serebryakova, Kseniya Agte, Sarita Kappes, Katerina Gleason, Charles R. Srivastava, Komal Almo, Steve Cordon-Cardo, Carlos Krammer, Florian Merad, Miriam Jagannath, Sundar Wajnberg, Ania Simon, Viviana Parekh, Samir Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients |
| title | Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients |
| title_full | Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients |
| title_fullStr | Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients |
| title_full_unstemmed | Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients |
| title_short | Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients |
| title_sort | augmentation of humoral and cellular immune responses after third-dose sars-cov-2 vaccination and viral neutralization in myeloma patients |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983835/ https://www.ncbi.nlm.nih.gov/pubmed/35390296 http://dx.doi.org/10.1016/j.ccell.2022.03.013 |
| work_keys_str_mv | AT alemanadolfo augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT vanoekelenoliver augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT upadhyayabhaskar augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT beachkatherine augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT koganzajdmanariel augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT alshammaryhala augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT serebryakovakseniya augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT agtesarita augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT kappeskaterina augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT gleasoncharlesr augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT srivastavakomal augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT almosteve augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT cordoncardocarlos augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT krammerflorian augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT meradmiriam augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT jagannathsundar augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT wajnbergania augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT simonviviana augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients AT parekhsamir augmentationofhumoralandcellularimmuneresponsesafterthirddosesarscov2vaccinationandviralneutralizationinmyelomapatients |